R estorative proctocolectomy and ileal pouch-anal anastomosis (IPAA) have been the surgical treatments of choice for patients with ulcerative colitis (UC) who require surgery. 1 The quality of life after IPAA is largely satisfactory, and the procedure has become less invasive with the advent of laparoscopic IPAA. [1] [2] [3] However, a substantial proportion of patients develop pouchitis, which lowers their quality of life. 4, 5 In particular, chronic pouchitis is very troublesome and may result in pouch failure or a permanent stoma. 6 In addition, long-term persistent inflammation in the pouch may cause neoplasia there, particularly for those with type C atrophic mucosa. 7 The treatment of pouchitis varies depending on the situation. Antibiotic therapy is the first choice in patients with acute pouchitis, but stronger treatment, such as corticosteroid or anti-tumor necrosis factor-a antibody treatment, may be necessary for those with chronic pouchitis. 8, 9 Although a preliminary study on 8 patients showed a possible short-term effectiveness of cytapheresis for treating pouchitis, 10 there are no high-evidence studies on the treatment of chronic pouchitis. Strong evidence shows that probiotic therapy using VSL#3 can prevent pouchitis. [11] [12] [13] If patients who are at a high risk of developing chronic pouchitis can be identified, surgery can be prolonged or probiotic therapy can be administered. One of the main risk factors for the development of pouchitis identified in Western populations is primary sclerosing cholangitis (PSC). 14, 15 In one cohort, this has also been shown to be the case in chronic pouchitis. 16 However, the incidence of PSC is much lower in Japan than in Western countries. 17 In addition, the incidence of pouchitis may vary among different ethnicities. 18 Therefore, risk factors in a Japanese population may be different from those in Western ones. 19 We reported that the presence of extraintestinal manifestations (EIMs) was an independent risk factor for the development of overall pouchitis in a Japanese cohort of only 58 patients in 2003, 20 but this previous study included the risk of acute pouchitis and was not limited to chronic pouchitis, which is a clinically difficult situation. The study had several limitations: the number of patients included was small and both preoperative and postoperative EIMs were considered. Although several other risk factors for the development of chronic pouchitis were identified in small cohorts, they were not necessarily reproduced in other cohorts.
Therefore, in this study, we updated and revised our cohort data of the previous study 20 to more accurately identify risk factors for the development of chronic pouchitis. We have updated the data of the previous study with data from 51 of 58 overlapping patients with longer follow-ups in addition to 49 new patients. Seven patients included in the previous study were excluded from this study because they had not undergone pouchoscopy after IPAA. We included only patients who underwent pouchoscopy, regardless of the symptoms of pouchitis in this study. To predict the risk of pouchitis using preoperatively obtained data, we confined variables to preoperative characteristics, including the presence of EIMs.
METHODS
Patients with UC who underwent IPAA and pouchoscopy between July 1989 and May 2016 were included. A total of 115 patients who underwent IPAA were followed at our institution, and 15 patients who had not undergone pouchoscopy for the functioning pouch and whose information was insufficient were excluded. Thus, 100 patients were included in this cohort. Patients' charts and endoscopic reports were retrospectively reviewed, and data were retrieved regarding basic patient background information, including sex, date of pouch operation, smoking history, age at UC onset, age during the operation, indication of operation, the presence or absence of preoperative EIMs, extent of UC, and type of operation (handsewn versus stapled IPAA). Pouchoscopy was performed when patients had symptoms indicative of pouchitis and annual surveillance pouchoscopy regardless of symptoms.
The primary endpoint was overall and chronic pouchitis. The cumulative incidence and risk factors for pouchitis were investigated. The duration between the date of the pouch operation and that of pouchoscopic diagnosis for pouchitis or final pouchoscopy date for patients without pouchitis was used.
Diagnosis of Chronic Pouchitis
The diagnosis of pouchitis was made according to the modified pouchitis activity index, 21 and modified pouchitis activity index values $5 were considered to be indicative of pouchitis. We further classified pouchitis into acute and chronic pouchitis according to the treatment efficacy based on Shen's recommendation. 22 If a patient was diagnosed as having pouchitis, antibiotics were administered. If a patient was responsive to a short 2 to 4-week course of antibiotics such as metronidazole and ciprofloxacin based on clinical symptoms, the disease was classified as acute pouchitis. Rifaximin was not used because it was not covered by medical insurance in Japan. If a patient relapsed after the discontinuation of antibiotic therapy and required more than a 4-week course of antibiotics, the disease was classified as chronic pouchitis. In addition, if a patient was unresponsive to a 4-week course of antibiotic therapy and required stronger treatment, the disease was classified as chronic pouchitis, in which case oral or topical 5-aminosalicylic acid, topical steroids, immunomodulators, cytapheresis, or an anti-tumor necrosis factora antibody was used at the doctor's discretion. The conditions referred to as "Crohn's disease of the pouch," in which concurrent afferent limb inflammation and fistulas are observed, 23 were considered to be in a different category from pouchitis. We thus excluded such conditions from the category of chronic pouchitis in this study.
Statistical Analysis
The EZR (Easy R) program in the free R software environment for statistical computing, and graphics (https:// www.R-project.org/) was used for statistical analysis. 24 The Cox regression test was used for multivariate analysis to identify risk factors for the development of pouchitis. Variables with a P value of ,0.20 by univariable analysis were included in the Cox regression test. Kaplan-Meier curves were used to estimate the incidence of pouchitis after IPAA.
Ethical Considerations
This study was approved by the ethics committee of The University of Tokyo (review number 3252- [1] ).
RESULTS

Incidence of Pouchitis
Totally, 641 pouchoscopy sessions (median of 5 sessions per patient, range [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] were performed for the functioning pouch in 100 patients who underwent IPAA. The background demographics of the included patients included are shown in Table 1 . The median follow-up time after IPAA was 125 months (range, 5-251 months). Twenty-two (22%) patients developed pouchitis, which was determined on the basis of the modified pouchitis activity index, in our series. The incidences of overall pouchitis were 5.4%, 13.7%, and 29.4% at 2, 5, and 10 years, respectively, after the pouch operation (Fig. 1A) . Six patients required continuous or intermittent antibiotics, and 6 other patients required more intensive therapy, such as treatment with an anti-tumor necrosis factor-a antibody or cytapheresis. Taken together, 12 patients had chronic pouchitis. The incidences of chronic pouchitis were 3.3%, 7.6%, and 16.6% at 2, 5, and 10 years, respectively, after the pouch operation (Fig. 1B) . Three other patients were considered to have Crohn's disease of the pouch.
Risk Factors for Pouchitis
Fifteen patients had preoperative EIMs. Totally, 18 EIMs were identified (Table 2) . PSC was identified preoperatively and postoperatively in only 1 patient each, and both had not developed pouchitis. Univariable analysis revealed that the presence of preoperative EIMs was a significant risk factor for the development of overall pouchitis, as shown in Table 3 and Figure 2A (hazard ratio [HR]: 3.75, 95% confidence interval [CI], 1.55-9.09, P ¼ 0.002). Univariable analysis revealed that the presence of preoperative EIMs was a significant risk factor for the development of chronic pouchitis (HR: 4.52, 95% CI, 1.42-14.41, P ¼ 0.011). Other factors, including age at operation, UC onset, smoking history, extent of UC, family history of UC, and type of IPAA were not associated with the development of pouchitis in this data set. The cumulative 5-year overall pouchitis rate was 34.6% in patients with preoperative EIMs and 11.0% in those without. The cumulative 5-year chronic pouchitis rates were 13.9% and 6.4% for patients with and without EIMs, respectively. The log-rank test demonstrated that the cumulative pouchitis risk was significantly higher in patients with preoperative EIMs than in those without for both overall and chronic pouchitis (P ¼ 0.002 and P ¼ 0.005) (Fig. 2A,B, respectively) . The Cox regression test demonstrated that the presence of preoperative EIMs and extent of UC were significant risk factors for the development of overall pouchitis ( 
DISCUSSION
In this Japanese data set, the presence of preoperative EIMs was shown to be an independent risk factor for the development of both overall and chronic pouchitis. This finding was in agreement with the finding in previous studies in Western countries showing that the presence of EIMs was a risk factor for the development of chronic pouchitis. 25 Two studies from Japan did not show a significant association between the presence of EIMs and the development of chronic pouchitis. 19, 26 In these 2 studies, the prevalence of EIMs was so low that the 95% CI was too broad to reach the level of significance. We previously reported that the presence of EIMs was an independent risk factor for the development of overall pouchitis, but at that time, we mixed both preoperative and postoperative EIMs. In addition, we included deep vein thrombosis (DVT) in EIMs, which may not be associated with autoimmune mechanisms, although patients with DVT often had other EIMs as well. To avoid these 
Cumulative incidence of (A) overall and (B) chronic pouchitis. A, The incidences of overall pouchitis were 5.4%, 13.7%, and 29.4% at 2, 5, and 10 years, respectively, after the pouch operation. B, The incidences of chronic pouchitis were 3.3%, 7.6%, and 16.6% at 2, 5, and 10 years, respectively, after the pouch operation.
limitations of the previous study, we included only preoperative immune-related EIMs in this study. In this study, preoperative EIMs were confined to what had been preoperatively recorded.
The number of patients with each EIM is small; thus, we combined patients with EIMs and did not individually investigate each EIM.
Considering that pouchitis has occurred almost exclusively in patients with UC but rarely in those with familial adenomatous polyposis, 27 it is natural to postulate that the underlying mechanism for the development of pouchitis is an autoimmune response. Regarding EIM occurrence in relation to the timing of surgery in our cohort, none of the patients manifested pyoderma gangrenosum recurrence after stoma closure, and the status of PSC and uveitis did not change. We also observed several patients with certain kinds of postoperative EIM occurrence such as uveitis, PSC, and erythema nodosum after IPAA. One patient postoperatively developed uveitis when she had an episode of pouchitis. Patients with pouchitis who have not had preoperative EIMs may develop postoperative EIMs. In our data set, 1 patient with pouchitis developed uveitis after IPAA. Tyler et al 28 reported that the nod2insc polymorphism is associated with the development of chronic pouchitis in North America. Although this NOD2 polymorphism is rarely seen in Japan, patients with Crohn-like spectrum may be predisposed to chronic pouchitis. These previous results also support the hypothesis that patients who have multiple autoimmune targets (not only the colorectum but also other organs) are susceptible to the development of pouch inflammation.
The presence of PSC is a well-known risk factor for the development of pouchitis in Western countries. 16, 29 This also may be true in case of chronic pouchitis. One study from the United Kingdom found that the presence of PSC was a risk factor for the development of chronic pouchitis. 30 However, the incidence of PSC may depend on the ethnicity and geographical distribution. Only one (1%) patient had PSC preoperatively in our cohort, and we did not identify the presence of PSC as a risk factor for the development of pouchitis. The incidence of PSC has been reported to be much lower in Japan than in Western countries 17 and that study was underpowered for determining if the presence of PSC was associated with the development of pouchitis.
The extent of UC seemed to be significantly associated with the development of overall pouchitis from multivariable analyses. Only 10 patients with left-sided colitis were included in this study. Therefore, we considered it difficult to draw definite conclusions from this small amount of data. A larger cohort study might further unveil the association between the development of chronic pouchitis and extent of UC.
Other reported risk factors for the development of pouchitis include nonsteroidal anti-inflammatory drug use, 25 UC onset, 19 and nonsmoker status. 29 However, we could not reproduce the same results in our data set. These risk factors have not necessarily been supported by the results in other cohorts, probably because pouchitis is a heterogeneous disorder. 30 In contrast to these factors, the presence of EIMs has been shown to be a risk factor for the development of chronic pouchitis in several (but not all) studies. This consistency may be because of the strong association of the presence of EIMs with the development of chronic pouchitis. Integrated analysis, such as a meta-analysis, is needed to further corroborate these findings.
The incidences of chronic pouchitis were 3.3%, 7.6%, and 16.6% at 2, 5, and 10 years, respectively, after IPAA. Several studies that investigated the incidence of pouchitis among Japanese patients with UC have been reported. Okita et al 26 retrospectively investigated 233 patients with UC who underwent IPAA and reported that 66 (28.5%) patients developed overall pouchitis, of which 31 were eventually diagnosed with chronic pouchitis. Uchino et al 19 reported that the incidence of pouchitis was 10.7% after 10 years in the largest Japanese study at the time, which comprised 772 patients with UC. In these previous studies, it was unclear whether pouchoscopy was performed in all included patients. In addition, the risk factor was investigated with a log regression test, and therefore, they did not take censored cases into consideration. By contrast, this study included only those who had undergone pouchoscopy and clarified risk factors for the development of pouchitis using the Cox regression test, taking censored cases into consideration. The incidence of overall and chronic pouchitis in our cohort was slightly lower, but closer, to that in previous studies in Western countries. 22, 26, 29 Pouchitis is a heterogeneous disease with various causes. Acute pouchitis may be attributed more to microbial dysbiosis, whereas chronic pouchitis may be associated with host-immune responses. Pouchoscopy is vital to rule out irritable pouch syndromes, in which patients have pouchitis-like symptoms but no endoscopic inflammation, because antibiotics are not effective in irritable pouch syndromes. 22 Therefore, we performed pouchoscopy when patients had symptoms indicative of pouchitis, in addition to annual surveillance pouchoscopy regardless of symptoms.
This study has several limitations. First, this was a retrospective study consisting of 100 patients. We could not completely exclude selection biases because of the retrospective nature of the study and the relatively small number of included patients. The recording of preoperative EIMs was based on being captured in the medical notes, and it is conceivable that the capture of such entities may have varied over the long study period. The response to antibiotics was judged based on clinical symptoms. It would be more precise if pouchoscopy had also been performed immediately after treatment. Second, although the results of several studies from Western countries have supported our results and have shown that the presence of EIMs was a risk factor for the development of chronic pouchitis, the results of 2 studies from Japan did not show a significant association between the presence of EIMs and development of chronic pouchitis. These negative results may have been because the small fraction of patients with EIMs in those studies meant that the studies were underpowered and so could not accurately show an association. Therefore, a meta-analysis of several studies could be useful to provide a sufficient number of patients for accurately identifying risk factors.
In conclusion, we observed a positive association between the presence of preoperative EIMs and the development of subsequent chronic pouchitis. Comparison of the cumulative incidences of (A) overall and (B) chronic pouchitis between patients with and without EIMs. Those with EIMs (dotted line) had a significantly higher incidence of both overall and chronic pouchitis than those without EIMs (solid line) (P ¼ 0.002 for overall pouchitis and P ¼ 0.005 for chronic pouchitis).
